Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Other Operating Expenses (2016 - 2025)

Arcadia Biosciences' Other Operating Expenses history spans 12 years, with the latest figure at $750000.0 for Q1 2025.

  • For Q1 2025, Other Operating Expenses changed N/A year-over-year to $750000.0; the TTM value through Dec 2025 reached $750000.0, down 81.25%, while the annual FY2025 figure was $750000.0, 81.25% down from the prior year.
  • Other Operating Expenses reached $750000.0 in Q1 2025 per RKDA's latest filing, down from $4.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.0 million in Q2 2024 to a low of -$5.4 million in Q2 2021.
  • Average Other Operating Expenses over 5 years is -$66777.8, with a median of $58000.0 recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: plummeted 106.44% in 2021, then skyrocketed 101.07% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at -$480000.0 in 2021, then surged by 85.0% to -$72000.0 in 2022, then surged by 126.39% to $19000.0 in 2023, then surged by 20952.63% to $4.0 million in 2024, then crashed by 81.25% to $750000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Other Operating Expenses are $750000.0 (Q1 2025), $4.0 million (Q2 2024), and $19000.0 (Q1 2023).